study

Trisol Medical Announces Positive Results from U.S. Early Feasibility Study of Its Transcatheter Tricuspid Valve Replacement System

Results demonstrate a favorable safety profile and functional improvements in patients with severe tricuspid regurgitation including patients with reduced right…

2 days ago

New Study Reveals Organic NatureKnit Provides Greater Prebiotic Benefits Than Purified Fibers

MOMENCE, Ill., Jan. 21, 2026 /PRNewswire/ -- New research published in Frontiers in Nutrition has revealed the significant impact of Organic…

2 days ago

Study: “Reaching out” Tops the List of Most Overused Email Buzzwords

ZeroBounce analyzed more than one million real work emails to uncover the most common email clichés. SANTA BARBARA, Calif., Jan.…

2 days ago

More than two-thirds of investment managers prominently using AI to support front office, SimCorp study reveals

Key findings: Annual survey of 200 buy-side executives shows significant increase in AI adoption compared to the same time last…

4 days ago

Benitec Biopharma Provides Positive Long-Term Clinical Study Results for BB-301 Phase 1b/2a Clinical Trial Demonstrating Robust Efficacy and Continued Durability of Response

• Patient 1 of Cohort 1 has now completed the 24-month follow-up timepoint, and at month-24 post-treatment Patient 1 continued…

2 weeks ago

Global study targets dengue as disease threatens nearly half the world’s population

LISMORE, Australia, Dec. 18, 2025 /PRNewswire/ -- Thousands of dengue forecasting models have been published, but few have been tested…

1 month ago

NEXTCHEM (MAIRE) AWARDED A FEASIBILITY STUDY BY RHM FOR A PMMA-POLYMER CHEMICAL RECYCLING PLANT IN GERMANY BASED ON ITS PROPRIETARY NXRe TECHNOLOGY

NEXTCHEM will develop a site-specific feasibility study for a chemical plastic recycling plant, fully integrated within Röhm's existing facilities, processing…

1 month ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…

1 month ago

Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

December 11, 2025 18:22 ET  | Source: Mesoblast Limited NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO;…

1 month ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction in countable motor seizure frequency (CMSF)…

2 months ago